Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pyridoxine vs Placebo for Prevention of Doxil-Related Hand-Foot Syndrome
NCT00245050Phase 3Completed
- Sponsor
- Case Comprehensive Cancer Center
- Start
- Apr 2004
- Primary completion
- Apr 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in palmar-plantar erythrodysesthesia (PPE) comparing Pyridoxine with Placebo (2 arms). Primary endpoint: Number of Participants With Palmar-plantar Erythrodysesthesia (PPE). Started Apr 2004; status: completed.
02
Drugs
pyridoxine
03
Conditions
palmar-plantar erythrodysesthesia (PPE)
Beyond the preview
Go deeper on NCT00245050.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00245050.